Home > PJ (Current issue) > FIP Congress 2006 | Search

PJ Online homeThe Pharmaceutical Journal
Vol 277 (Supplement) F16
October 2006

This article
Reprint   Photocopy

PDF 30K, Acrobat Reader

Meetings

See FIP Reports

FIP Congress 2006

Jean Curtis reports from a session organised by the Industrial Pharmacy Section

World Congress of Pharmacy and Pharmaceutical Sciences The World Congress of Pharmacy and Pharmaceutical Sciences, the 66th International FIP Congress, was organised by the International Pharmaceutical Federation in association with the Federal Council of Pharmacy of Brazil.
It took place in Salvador da Bahia from August 26 to 31, 2006

How pharmacy curricula prepare students for a career in the industry

ARTICLE CONTENTS
How pharmacy curricula prepare students for a career in the industry

Courses around the world
• Brazil
• Czech Republic
• Denmark
• India
• Arab countries


Research presentations by students and young pharmacists

Ziba Ansari-Jaberi, of the Thomas J. Long school of pharmacy and health sciences (TJL), Stockton, California, presented a comparison of the pharmacy curriculum in the US and in Iran. The schools of pharmacy chosen were the Tehran University of Medical Sciences and Health Care Services and the TJL in the US.

Although both courses provide graduates with ample experience to be proficient pharmacists, significant differences were noted in entry requirements, programme content and length of time to qualification as a pharmacist.

For TJL most introductory courses are completed before admission, whereas for Tehran there is a greater number of basic introductory science courses. This allows the US course to be shorter — only three years, with graduates registering typically after about four years — whereas in Tehran the course leading to qualification as a pharmacist takes six years.

The course content at TJL produces graduates with a wide knowledge base who are more clinically orientated but less equipped to take up non-clinical roles in pharmaceutical industry, whereas that in Tehran contains industrial pharmacy field work, medicines quality control and pharmacognosy, all of which enable graduates to enter a career in the pharmaceutical industry more easily.

Sally Makady, a pharmacy undergraduate at the German University of Cairo, compared the US (University of Cincinnati), German and Egyptian (University of Ain Shams) curricula. Like the previous speaker, she also identified a difference in entry requirements between the US, the German and Egyptian universities, with US universities requiring completion of a “pre-pharmacy” programme, which the German and Egyptian universities do not.

The US programmes were again identified as producing more clinically oriented graduates. However, in terms of the industrial component of the curriculum there was a significant theoretical manufacturing and quality control component in the Egyptian university but little practical work, a limited amount of theory and practical work in the US system, but a significant component of both theory and practice in the German university. The German course was identified as being closest to the ideal industrial pharmacy curriculum.

Keon Green, a pharmacy intern from Jamaica, presented a comparison between the courses of the University of Havana, Cuba, and the Purdue University, Indiana, US. Like Egypt, Havana devoted part of the course to the theory of industrial pharmacy practice but for the practical aspects there is limited access to instruments and equipment. This part of the course was compulsory, but the much of the industrial course at Purdue was elective. It is possible to take an industrial pharmacy course at Purdue, but this will not allow subsequent registration as a pharmacist.

Courses around the world

Following the presentations, members of the audience were invited by the chairman to describe the pharmacy undergraduate course in their countries:

• Brazil The pharmacy course contains a core curriculum consisting of the minimum required for a pharmacist, with elective subjects to be taken in addition.

• Czech Republic There is a three-year core course then a choice from community pharmacy, clinical pharmacy or technical (industrial) pharmacy.

• Denmark There is an industrial pharmacy course since 60 per cent of pharmacists in Denmark work in industry.

• India The government has determined the content of the curriculum, which is focused towards the industry.

• Arab countries The World Health Organization is working on developing a common core curriculum for 22 Arab countries (and Afghanistan) through a study of the curriculum in each country. Wide variations have been found: whereas Saudi Arabia has an emphasis on clinical studies, in a number of other countries industrial studies feature prominently.

During the session there was a brief discussion on the reasons for the differences in the pharmacy courses in different countries. Where more jobs were available in the pharmaceutical industry the undergraduate courses tended to have a greater course content applicable to industrial work. However, in the less affluent countries, equipment and facilities tend to be limited making practical work more difficult.

The idea of the “ideal industrial pharmacy curriculum” was discussed briefly. The view was expressed that, since the pharmaceutical industry is largely organised on a global scale, it might be possible to devise an internationally harmonised curriculum taking, where possible, the best from the courses in the various countries. However, the needs of individual countries would dictate the exact content.

Research presentations by students and young pharmacists

Sunscreens Yasmin Goman, from the University of Alexandria, Egypt, demonstrated the potential for chitosan microspheres to be used in a sunscreen delivery system. Chitosan is a modified carbohydrate polymer derived from the chitin component of the shells of crustaceans.

She showed that chitosan has the properties needed for a good sunscreen delivery system, such as minimal skin penetration, and the ability to release the active substance in a controlled manner allowing reduced frequency of application, but in particular that chitosan itself has photoprotective properties.

HPLC Lucie Novakova, of Charles University, Hradec Kralove, Czech Republic, talked about three new aspects of high performance liquid chromatography (HPLC). She showed that these all have the potential to reduce time taken to analyse medicinal products during production, that they meet the quality standards required for analysis of medicinal products and that they reduce the amounts of solvents used in the process, thus reducing overall production costs.

Conventional HPLC columns use small spherical particles of silica. The first new technique was to replace these particles with a special type of silica in the form of one piece of porous monolith material, “monolith columns”. The second was to replace the conventional particles with very small particles of around 3.5 microns diameter and the third to use ultra performance liquid chromatography, which uses high pressure of up to 100MPa (15,000 PSI) and X-bridge sorbents (bridged ethylsiloxane/silica hybrid technology) in the columns.

Paracetamol Vladi Consiglieri, of the University of Sao Paulo, Brazil, described work to find a better method to produce paracetamol tablets. These are currently manufactured by a wet granulation process, as pure paracetamol has poor compression and flow characteristics, and the tablets have a tendency to cap.

The use of direct compression for tablet production requires paracetamol to be produced in a special form to improve its compaction properties. The work examined the use of paracetamol mixed with various other materials in different proportions to try to find a suitable mixture for tablet production by direct compression using conventional raw materials and equipment. A suitable mixture containing 70 per cent paracetamol has been identified.


©The Pharmaceutical Journal